As reported by Raps (Brennan, 2017) the UK set in motion Britian’s exit from the EU with a departure over the next two years. EMA’s headquarters will leave London for another EU country. Bresit and the EMA could be interesting.
Will reloaction of EMA headquarters to another EU country result in a relocation of the existing EMA staff? Will the EU replace all or a core group of the London EMA staff? Will this potential change in staff and EMA leadership change its focus, approach, methods? What impact will the relocation have on the approval pipeline? Interesting times ahead.